• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体非依赖性调控因子 H 对甲型流感病毒感染的作用

Complement-Independent Modulation of Influenza A Virus Infection by Factor H.

机构信息

Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom.

School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.

出版信息

Front Immunol. 2020 Mar 25;11:355. doi: 10.3389/fimmu.2020.00355. eCollection 2020.

DOI:10.3389/fimmu.2020.00355
PMID:32269562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7109256/
Abstract

The complement system is an ancient innate immune defense mechanism that can recognize molecular patterns on the invading pathogens. Factor H, as an inhibitor of the alternative pathway, down-regulates complement activation on the host cell surface. Locally synthesized factor H at the site of infection/injury, including lungs, can act as a pattern recognition molecule without involving complement activation. Here, we report that factor H, a sialic acid binder, interacts with influenza A virus (IAV) and modulates IAV entry, as evident from down-regulation of matrix protein 1 (M1) in H1N1 subtype-infected cells and up-regulation of M1 expression in H3N2-infected A549 cells. Far-western blot revealed that factor H binds hemagglutinin (HA, 70 kDa), neuraminidase (NA, ~60 kDa), and M1 (25 kDa). IAV-induced transcriptional levels of IFN-α, TNF-α, IL-12, IL-6, IFN-α, and RANTES were reduced following factor H treatment for the H1N1 subtype at 6 h post-infection. However, for the H3N2 subtype, mRNA levels of these pro-inflammatory cytokines were enhanced. A recombinant form of vaccinia virus complement control protein (VCP), which like factor H, contains CCP modules and has complement-regulatory activity, mirrored the results obtained with factor H. Both factor H (25%), and VCP (45%) were found to reduce luciferase reporter activity in MDCK cells transduced with H1N1 pseudotyped lentiviral particles. Factor H (50%) and VCP (30%) enhanced the luciferase reporter activity for H3N2, suggesting an entry inhibitory role of factor H and VCP against H1N1, but not H3N2. Thus, factor H can modulate IAV infection and inflammatory responses, independent of its complement-related functions.

摘要

补体系统是一种古老的先天免疫防御机制,能够识别入侵病原体上的分子模式。因子 H 作为旁路途径的抑制剂,下调宿主细胞表面的补体激活。在感染/损伤部位合成的局部因子 H,包括肺部,可以作为一种模式识别分子,而不涉及补体激活。在这里,我们报告因子 H(一种唾液酸结合蛋白)与甲型流感病毒(IAV)相互作用并调节 IAV 进入,这从 H1N1 亚型感染细胞中基质蛋白 1(M1)的下调和 H3N2 感染的 A549 细胞中 M1 表达的上调中可以明显看出。远 Western blot 显示因子 H 结合血凝素(HA,70 kDa)、神经氨酸酶(NA,60 kDa)和 M1(~25 kDa)。在 H1N1 亚型感染后 6 小时,因子 H 处理可降低 IAV 诱导的 IFN-α、TNF-α、IL-12、IL-6、IFN-α 和 RANTES 的转录水平。然而,对于 H3N2 亚型,这些促炎细胞因子的 mRNA 水平增强。含有 CCP 模块并具有补体调节活性的痘苗病毒补体控制蛋白(VCP)的重组形式与因子 H 的结果相似。在转导 H1N1 假型慢病毒颗粒的 MDCK 细胞中,因子 H(25%)和 VCP(45%)均降低荧光素酶报告基因活性。因子 H(50%)和 VCP(30%)增强了 H3N2 的荧光素酶报告基因活性,表明因子 H 和 VCP 对 H1N1 具有抑制作用,但对 H3N2 没有抑制作用。因此,因子 H 可以调节 IAV 感染和炎症反应,而不依赖其补体相关功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/58bb762edd9f/fimmu-11-00355-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/bda3ae96d3a8/fimmu-11-00355-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/71a7d92d9e83/fimmu-11-00355-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/286f0d7dfc11/fimmu-11-00355-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/a92e6e5df45b/fimmu-11-00355-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/0ee9eb9fc62d/fimmu-11-00355-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/d8fb7421becc/fimmu-11-00355-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/58bb762edd9f/fimmu-11-00355-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/bda3ae96d3a8/fimmu-11-00355-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/71a7d92d9e83/fimmu-11-00355-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/286f0d7dfc11/fimmu-11-00355-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/a92e6e5df45b/fimmu-11-00355-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/0ee9eb9fc62d/fimmu-11-00355-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/d8fb7421becc/fimmu-11-00355-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d2/7109256/58bb762edd9f/fimmu-11-00355-g0007.jpg

相似文献

1
Complement-Independent Modulation of Influenza A Virus Infection by Factor H.补体非依赖性调控因子 H 对甲型流感病毒感染的作用
Front Immunol. 2020 Mar 25;11:355. doi: 10.3389/fimmu.2020.00355. eCollection 2020.
2
Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.浸润中性粒细胞释放的人补体因子 H 可调节甲型流感病毒感染。
Front Immunol. 2021 Dec 9;12:747654. doi: 10.3389/fimmu.2021.747654. eCollection 2021.
3
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus.C4 结合蛋白作为抗甲型流感病毒的固有免疫效应因子。
Front Immunol. 2021 Jan 8;11:585361. doi: 10.3389/fimmu.2020.585361. eCollection 2020.
4
Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.重组短链表面活性蛋白 D 对甲型流感病毒的入胞抑制和促炎免疫反应的调节作用。
Front Immunol. 2018 Jul 30;9:1586. doi: 10.3389/fimmu.2018.01586. eCollection 2018.
5
Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain.人 C1q 通过其球形结构域调节甲型流感病毒感染和炎症反应。
Int J Mol Sci. 2022 Mar 11;23(6):3045. doi: 10.3390/ijms23063045.
6
Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.全长人表面活性剂蛋白 A 抑制 A549 肺上皮细胞感染流感 A 病毒:含有颈区和凝集素结构域的重组形式促进感染性。
Immunobiology. 2019 May;224(3):408-418. doi: 10.1016/j.imbio.2019.02.006. Epub 2019 Feb 11.
7
Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.甲型流感病毒携带人或禽流感非结构蛋白 1 对人原代细胞固有免疫反应的差异调节。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.00999-19.
8
Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.地榆素通过下调 NF-κB 信号转导通路抑制甲型流感病毒复制。
Virol J. 2018 May 21;15(1):88. doi: 10.1186/s12985-018-0995-6.
9
Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.从鸡骨常山提取的总生物碱通过调节先天免疫应答抑制流感病毒复制和肺部免疫病理。
Phytomedicine. 2020 Oct;77:153272. doi: 10.1016/j.phymed.2020.153272. Epub 2020 Jun 29.
10
Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.新型聚酮化合物PPQ-B通过干扰细胞表皮生长因子受体(EGFR)途径对甲型流感病毒复制的抑制作用。
Antiviral Res. 2017 Jul;143:74-84. doi: 10.1016/j.antiviral.2017.04.007. Epub 2017 Apr 13.

引用本文的文献

1
Differential modulation of SARS-CoV-2 infection by complement factor H and properdin.补体因子H和备解素对严重急性呼吸综合征冠状病毒2感染的差异调节作用
Front Immunol. 2025 Aug 15;16:1620229. doi: 10.3389/fimmu.2025.1620229. eCollection 2025.
2
T Cell Responses to Influenza Infections in Cattle.牛对流感感染的T细胞反应。
Viruses. 2025 Aug 14;17(8):1116. doi: 10.3390/v17081116.
3
Innate Immune Response to Viral Infection.对病毒感染的固有免疫反应

本文引用的文献

1
Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.重组短链表面活性蛋白 D 对甲型流感病毒的入胞抑制和促炎免疫反应的调节作用。
Front Immunol. 2018 Jul 30;9:1586. doi: 10.3389/fimmu.2018.01586. eCollection 2018.
2
The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-β Production by Targeting TNF Receptor-Associated Factor 3.甲型流感病毒非结构蛋白1的C末端效应结构域通过靶向肿瘤坏死因子受体相关因子3阻断IFN-β的产生。
Front Immunol. 2017 Jul 3;8:779. doi: 10.3389/fimmu.2017.00779. eCollection 2017.
3
Adv Exp Med Biol. 2025;1476:199-224. doi: 10.1007/978-3-031-85340-1_8.
4
Mapping the interaction sites of human and avian influenza A viruses and complement factor H.绘制甲型人流感病毒和禽流感病毒与补体因子H的相互作用位点
Front Immunol. 2024 Apr 18;15:1352022. doi: 10.3389/fimmu.2024.1352022. eCollection 2024.
5
Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.髓系 Zfhx3 缺乏可防止高碳酸血症引起的宿主对甲型流感病毒防御的抑制。
JCI Insight. 2024 Jan 16;9(4):e170316. doi: 10.1172/jci.insight.170316.
6
Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain.人 C1q 通过其球形结构域调节甲型流感病毒感染和炎症反应。
Int J Mol Sci. 2022 Mar 11;23(6):3045. doi: 10.3390/ijms23063045.
7
New Insights into the Role of the Complement System in Human Viral Diseases.补体系统在人类病毒病中的作用新见解。
Biomolecules. 2022 Jan 28;12(2):226. doi: 10.3390/biom12020226.
8
Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.浸润中性粒细胞释放的人补体因子 H 可调节甲型流感病毒感染。
Front Immunol. 2021 Dec 9;12:747654. doi: 10.3389/fimmu.2021.747654. eCollection 2021.
9
Emerging roles of the complement system in host-pathogen interactions.补体系统在宿主-病原体相互作用中的新作用。
Trends Microbiol. 2022 Apr;30(4):390-402. doi: 10.1016/j.tim.2021.09.002. Epub 2021 Sep 29.
10
Altered Signal Transduction in the Immune Response to Influenza Virus and or Co-Infections.免疫应答流感病毒及(或)合并感染中信号转导的改变。
Int J Mol Sci. 2021 May 22;22(11):5486. doi: 10.3390/ijms22115486.
Comparison of infectious influenza A virus quantification methods employing immuno-staining.
采用免疫染色的甲型流感病毒感染性定量方法比较
J Virol Methods. 2017 Sep;247:107-113. doi: 10.1016/j.jviromet.2017.06.004. Epub 2017 Jun 10.
4
Drug resistance in influenza A virus: the epidemiology and management.甲型流感病毒的耐药性:流行病学与管理
Infect Drug Resist. 2017 Apr 20;10:121-134. doi: 10.2147/IDR.S105473. eCollection 2017.
5
The cell surface mucin MUC1 limits the severity of influenza A virus infection.细胞表面黏蛋白 MUC1 可限制甲型流感病毒感染的严重程度。
Mucosal Immunol. 2017 Nov;10(6):1581-1593. doi: 10.1038/mi.2017.16. Epub 2017 Mar 22.
6
Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders.补体因子H在自身免疫性炎症和血栓形成性疾病中的潜在影响。
Mol Immunol. 2017 Apr;84:84-106. doi: 10.1016/j.molimm.2017.01.015. Epub 2017 Feb 16.
7
Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.促炎细胞因子对流感后易并发肺炎链球菌感染的级联效应。
Sci Rep. 2016 Nov 22;6:37045. doi: 10.1038/srep37045.
8
Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus.预测H7亚型流感病毒血凝素保守B细胞表位的计算方法
Exp Ther Med. 2016 Oct;12(4):2439-2446. doi: 10.3892/etm.2016.3636. Epub 2016 Aug 31.
9
Complement factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine response.补体因子H可干扰牛分枝杆菌卡介苗进入巨噬细胞,并调节促炎细胞因子反应。
Immunobiology. 2016 Sep;221(9):944-52. doi: 10.1016/j.imbio.2016.05.011. Epub 2016 May 24.
10
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.神经氨酸酶(NA)在流感病毒生命周期中的新作用:对开发具有新型作用机制的NA抑制剂的启示。
Rev Med Virol. 2016 Jul;26(4):242-50. doi: 10.1002/rmv.1879. Epub 2016 Apr 8.